OverviewSuggest Edit

Cogentix Medical, Inc. is a global medical company that provides proprietary, innovative technologies to specialty markets including urology, gynecology, bariatric medicine, critical care, gastroenterology, otolaryngology, and pulmonology. The Company designs, develops, manufactures and markets a  line of high-performance fiber optic and video endoscopy products under the PrimeSight brand that are used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix also offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation, for the office-based treatment of overactive bladder as well as Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency.

TypePublic
Founded1987
HQMinnetonka, US
Websitecogentixmedical.com
Employee Ratings4

Latest Updates

Employees (est.) (Sep 2017)178
Revenue (FY, 2017)$56.3 M(+9%)
Share Price (May 2018)$3.8 (+46%)

Cogentix Medical Office Locations

Cogentix Medical has offices in Minnetonka, Orangeburg, Westborough, Geleen and in 1 other location
Minnetonka, US (HQ)
5420 Feltl Rd
Orangeburg, US
40 Ramland Rd
Westborough, US
135 Flanders Rd
Geleen, NL
2 Hofkamp
Wythenshawe, GB
3000 Aviator Way
Show all (5)

Cogentix Medical Financials and Metrics

Cogentix Medical Revenue

Embed Graph
View revenue for all periods
Cogentix Medical's revenue was reported to be $56.32 m in FY, 2017 which is a 8.6% increase from the previous period.
USD

Revenue (FY, 2017)

56.3m

Revenue growth (FY, 2016 - FY, 2017), %

8.6%

Gross profit (FY, 2017)

37.4m

Gross profit margin (FY, 2017), %

66.5%

Net income (FY, 2017)

(882.7k)

EBIT (FY, 2017)

(889.5k)

Market capitalization (31-May-2018)

234.5m

Closing stock price (31-May-2018)

3.8

Cash (31-Dec-2017)

20.9m
Cogentix Medical's current market capitalization is $234.5 m.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

26.5m51.9m56.3m

Revenue growth, %

95%9%

Cost of goods sold

3.1m16.2m18.9m

Gross profit

23.4m35.6m37.4m
Quarterly
USDQ1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

11.2m11.8m12.2m13.0m13.4m13.0m14.1m13.8m

Cost of goods sold

3.7m4.0m3.8m4.1m4.4m4.5m4.7m4.4m

Gross profit

7.5m7.9m8.4m8.9m9.0m8.5m9.4m9.4m

Gross profit Margin, %

67%67%69%69%67%65%67%68%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

1.2m9.3m9.4m20.9m

Accounts Receivable

7.3m6.8m8.3m

Inventories

4.2m4.8m7.2m7.2m

Current Assets

9.7m22.1m37.5m43.7m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

1.3m1.4m1.5m6.0m2.9m2.2m2.9m4.2m5.7m10.4m15.4m

Accounts Receivable

6.5m6.5m6.9m6.5m6.8m6.7m7.3m7.2m

Inventories

4.2m4.2m4.3m4.9m5.0m5.0m5.7m6.2m7.6m7.2m7.4m

Current Assets

9.2m9.0m10.4m18.2m16.0m14.9m15.8m19.1m36.7m39.9m41.6m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.7m)(7.7m)(22.1m)(882.7k)

Depreciation and Amortization

695.0k279.0k3.1m3.2m

Inventories

692.0k140.6k(2.7m)276.1k

Accounts Payable

(83.0k)231.7k484.2k(90.3k)
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(2.0m)(3.5m)(1.6m)(3.6m)(5.9m)(966.4k)(3.6m)(3.5m)(1.2m)(790.8k)(950.9k)

Depreciation and Amortization

318.0k853.2k1.7m806.6k1.6m2.4m769.8k1.5m2.3m

Inventories

(261.0k)(44.0k)(134.7k)(447.7k)(1.1m)(1.6m)(373.7k)7.3k57.3k

Accounts Payable

188.0k(90.0k)(647.3k)13.5k104.1k394.6k(702.0k)(1.1m)(898.8k)
USDY, 2017

Revenue/Employee

316.4k

Financial Leverage

1.2 x
Show all financial metrics

Cogentix Medical Online and Social Media Presence

Embed Graph

Cogentix Medical News and Updates

Global Bronchoscopes Market Analysis & Forecast (2018-2025): Teleflex, Olympus, Fujifilm, Boston Scientific, and Cogentix Medical are Dominating the $29.6 Billion Projected Market

DUBLIN, Oct 31, 2018 /PRNewswire/ -- The "Bronchoscopes Market Size, Share & Trends Analysis Report By Use (Reusable, Disposable), By Type (Flexible (Video, Fiberoptic, Hybrid), Rigid), By Region, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's...

Cogentix Medical, Inc. / Laborie Medical Technologies Canada ULC Merger Litigation

TORONTO, Oct. 5, 2018 /PRNewswire/ -- On March 11, 2018, Cogentix Medical, Inc. ("Cogentix") and certain affiliates of Laborie Medical Technologies Canada ULC ("Laborie"), LM US Parent, Inc. ("Parent") and Camden Merger Sub, Inc. ("Merger Sub"), entered into an Agreement and Plan of...

Cogentix Medical Frequently Asked Questions

  • When was Cogentix Medical founded?

    Cogentix Medical was founded in 1987.

  • How many employees does Cogentix Medical have?

    Cogentix Medical has 178 employees.

  • What is Cogentix Medical revenue?

    Latest Cogentix Medical annual revenue is $56.3 m.

  • What is Cogentix Medical revenue per employee?

    Latest Cogentix Medical revenue per employee is $316.4 k.

  • Who are Cogentix Medical competitors?

    Competitors of Cogentix Medical include STAAR Surgical, Glaukos and Vesper Medical.

  • Where is Cogentix Medical headquarters?

    Cogentix Medical headquarters is located at 5420 Feltl Rd, Minnetonka.

  • Where are Cogentix Medical offices?

    Cogentix Medical has offices in Minnetonka, Orangeburg, Westborough, Geleen and in 1 other location.

  • How many offices does Cogentix Medical have?

    Cogentix Medical has 5 offices.